Correlation Between A1LN34 and Novo Nordisk

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both A1LN34 and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining A1LN34 and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between A1LN34 and Novo Nordisk AS, you can compare the effects of market volatilities on A1LN34 and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in A1LN34 with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of A1LN34 and Novo Nordisk.

Diversification Opportunities for A1LN34 and Novo Nordisk

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between A1LN34 and Novo is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding A1LN34 and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and A1LN34 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on A1LN34 are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of A1LN34 i.e., A1LN34 and Novo Nordisk go up and down completely randomly.

Pair Corralation between A1LN34 and Novo Nordisk

Assuming the 90 days trading horizon A1LN34 is expected to generate 0.85 times more return on investment than Novo Nordisk. However, A1LN34 is 1.18 times less risky than Novo Nordisk. It trades about 0.01 of its potential returns per unit of risk. Novo Nordisk AS is currently generating about -0.12 per unit of risk. If you would invest  7,399  in A1LN34 on September 24, 2024 and sell it today you would lose (49.00) from holding A1LN34 or give up 0.66% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

A1LN34  vs.  Novo Nordisk AS

 Performance 
       Timeline  
A1LN34 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days A1LN34 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, A1LN34 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

A1LN34 and Novo Nordisk Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with A1LN34 and Novo Nordisk

The main advantage of trading using opposite A1LN34 and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if A1LN34 position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.
The idea behind A1LN34 and Novo Nordisk AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges